[HTML][HTML] Ischemia with Nonobstructive Coronary Artery Disease and Atrial Cardiomyopathy—Two Sides of the Same Story?
Ischemia with nonobstructive coronary artery disease (INOCA) is increasingly recognized as
a significant cause of angina, myocardial remodeling, and eventually heart failure (HF) …
a significant cause of angina, myocardial remodeling, and eventually heart failure (HF) …
Evaluation of the Efficacy of Sacubitril/Valsartan on Radiofrequency Ablation in Patients with Hypertension and Persistent Atrial Fibrillation
X Zang, Z Zhao, K Chen, W Song, J Ma, Y Zhou… - … Drugs and Therapy, 2023 - Springer
Objective To evaluate whether the effect of radiofrequency ablation can be improved by
using sacubitril/valsartan (S/V) to control blood pressure in hypertensive patients with …
using sacubitril/valsartan (S/V) to control blood pressure in hypertensive patients with …
[PDF][PDF] 沙库巴曲缬沙坦对持续性心房颤动导管消融术后临床疗效的影响: 基于倾向性评分的单中心队列研究
梁晓芳， 李文华， 宋艳斌， 薛社亮， 王娟， 凤伟祥… - 高血压杂志, 2021 - lcxxg.whuhzzs.com
目的: 探讨沙库巴曲缬沙坦对持续性心房颤动(房颤) 导管消融术后中远期预后的影响. 方法:
回顾性分析我院2019 年1 月—2022 年11 月因持续性房颤行导管消融术的患者210 例 …
回顾性分析我院2019 年1 月—2022 年11 月因持续性房颤行导管消融术的患者210 例 …
Effect of sacubitril/valsartan on clinical outcomes in patients with persistent atrial fibrillation undergoing catheter ablation: a single-center cohort study using propensity …
L Xiaofang, LI Wenhua, S Yanbin, XUE Sheliang… - J Clin …, 2023 - en.whuhzzs.com
Effect of sacubitril/valsartan on clinical outcomes in patients with persistent atrial fibrillation
undergoing catheter ablation: a single-center cohort study using propensity score matching …
undergoing catheter ablation: a single-center cohort study using propensity score matching …